Bank Of New York Mellon Corp Vincerx Pharma, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.0 - $0.0 $0 - $0	-59,434 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$0.0 - $0.0 $0 - $0	8,850 Added 17.5%	59,434 $605,000
Q3 2021 Nov 12, 2021	BUY	$0.0 - $0.0 $0 - $0	38,570 Added 321.04%	50,584 $818,000
Q2 2021 Aug 11, 2021	BUY	$0.0 - $27.0 $0 - $324,378	12,014 New	12,014 $0

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $3.18M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.